Artificial intelligence beat 15 doctors from top centers 2-0 in tumor diagnosis
The effectiveness of Artificial Intelligence in the field of medicine is increasing day by day. In the competition held between 15 specialist doctors selected from the best hospitals in China and the newly developed artificial intelligence program called BioMind, the program doctors were defeated 2-0. Developed by researchers from the Neurological Disorders Research Center and Capital Medical University, BioMind made an accurate diagnosis in 87% of 225 cases in about 15 minutes. Moreover, BioMind was not only able to diagnose brain tumors in its diagnoses, but was also better able to make a detailed diagnosis and problems in the cerebral vessels. In the race held in Beijing recently, AI also successfully diagnosed brain hematoma enlargement cases and 83% of tumor cases, while the correct diagnosis rate of doctors was only 63% accurate.
A team of 15 doctors from the best hospitals in China could diagnose cases with an accuracy of 66% in 30 minutes, while BioMind achieved more accurate results in a much shorter time. BioMind provided up to 87% accuracy when diagnosing brain tumors and predicting brain hemorrhages. The vice president of Beijing Tiantan Hospital, which hosts the research center, Dr. Wang Yongjun emphasized that they were not surprised by the results obtained and that the learning process of the artificial intelligence program continues, and that the accuracy rates may increase further in the near future.
Artificial intelligence ‘better than cardiologists’ in diagnosing heart diseases
Being a jury member in the competition, Antwerp University Hospital Radiology Unit Head Prof. Paul Parizel, “Artificial Intelligence will be just like a GPS guiding a car. He will offer advice to a doctor and help him very comprehensively so that the doctor can make a better diagnosis. But in the end, it will be the doctor who makes the final decision.”
To train the BioMind program, the developers used tens of thousands of images of nervous system-related diseases that Tiantan Hospital has archived over the past 10 years, enabling diagnostic success in neurological diseases with an accuracy rate of over 90%. Professor of Radiology at Zhengzhou University, China. Cheng Jingliang explained that the current artificial intelligence program is still successfully used by the doctor for lung scans and disease diagnosis in some Chinese hospitals.
The use of artificial intelligence in Hematology and Oncology is increasing rapidly!
Experts especially emphasize that despite all these positive developments, the use of artificial intelligence in medicine is still in its infancy, and that Artificial Intelligence has not shown the same success in all areas of medicine for now, and in some cases it lags far behind physicians. However, despite its short history, artificial intelligence applications have shown great success and this is promising for the future.
Artificial Intelligence technologies, which are strongly encouraged by the Chinese government, have been widely used in medical fields in China in recent years. In June, Swedish medical company Elekta introduced Watson for Oncology, a medical system developed in the US by IBM to provide customized treatment plans for cancer patients in China. The program is currently used in 68 hospitals across China for cancer diagnosis and treatment. .Source: www.chinadaily.com.cn